Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imaging features of gastrointestinal toxicity in non-small cell lung cancer patients treated with erlotinib: A single institute 13-year experience.

Clinical imaging - 1 Dec 2020

Pfau David, Guler Ezgi, Smith Daniel A, Matsunaga Felipe, Kikano Elias G, Tirumani Sree Harsha, Dowlati Afshin, Ramaiya Nikhil H

Abstract excerpt

OBJECTIVES: To investigate the imaging features of erlotinib-associated gastrointestinal toxicity (GT) in patients with non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: The electronic medical records of 157 patients with NSCLC who received erlotinib between 2005 and 2018 were retrospectively reviewed to identify patients with GT. Clinical and radiologic evidence of erlotinib-associated GT was evaluated....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erlotinib Hydrochloride

Share to Lung Neoplasms

Share to Mutation

Share to Treatment Outcome

Source

Identifiers

PMID: 32892106
DOI: 10.1016/j.clinimag.2020.08.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imaging features of gastrointestinal toxicity in non-small cell lung cancer patients treated with erlotinib: A single institute 13-year experience.PMID 32892106Read ↗

Incidence, Treatment and Outcomes of Patients with Synchronous Lung and Colorectal Malignancies: A Nationwide Inpatient Sample Database (NIS) AnalysisSemantic proximity Read ↗

Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report.Semantic proximity Read ↗

Gastrointestinal perforation following dabrafenib and trametinib administration in non-small cell lung carcinoma with BRAF V600E mutation: a case report and literature reviewSemantic proximity Read ↗

Colonic mucosal diffuse congestion associated with Osimertinib.Semantic proximity Read ↗

Gastric and rectal administration of encorafenib with targeted chemotherapy against BRAF V600E-mutant rectal cancer with bowel obstruction.Semantic proximity Read ↗

Undifferentiated large cell/rhabdoid carcinoma presenting in the intestines of patients with concurrent or recent non-small cell lung cancer (NSCLC): clinicopathologic and molecular analysis of 14 cases indicates an unusual pattern of dedifferentiated metastases.Semantic proximity Read ↗

Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report.Semantic proximity Read ↗

Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis.Semantic proximity Read ↗

Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report.Semantic proximity Read ↗

Eye, Hepatobiliary, and Renal Disorders of Erlotinib in Patients with Non-Small-Cell Lung Cancer: A Meta-AnalysisSemantic proximity Read ↗

Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome: A case report.Semantic proximity Read ↗

An Unusual Presentation of a Newly Diagnosed Right Colonic Adenocarcinoma Complicated with Right Lower Quadrant Colonic Abscess in an Elderly Man: A Case Report and Literature ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.